Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period

Vaccine

Volumn 30, Issue 27, 2012, Pages 4067-4072

  De Serres, Gaston ^a   Pilishvili, Tamara ^b   Link Gelles, Ruth ^b   Reingold, Arthur ^c   Gershman, Kenneth ^d   Petit, Susan ^e   Farley, Monica M ^f   Harrison, Lee H ^g   Lynfield, Ruth ^h   Bennett, Nancy M ⁱ   Baumbach, Joan ^j   Thomas, Ann ^k   Schaffner, William ^l   Beall, Bernard ^b   Whitney, Cynthia ^b   Moore, Matthew ^b  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Colorado Department of Public Health and Environment ^*  (United States)

^e CDC   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h MINNESOTA DEPARTMENT OF HEALTH   (United States)

ⁱ UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^j Public Health Division ^*

^k Vanderbilt University School of Medicine   (United States)

^l VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Indirect cohort method; Pneumococcal conjugate vaccine; Vaccine effectiveness

Indexed keywords

PNEUMOCOCCAL CONJUGATE VACCINE 7; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CHILD; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; VACCINATION;

BACTEREMIA; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT; MALE; MENINGITIS, PNEUMOCOCCAL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; TREATMENT OUTCOME;

EID: 84861480714     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.017     Document Type: Article

References (18)

1. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Northern California Kaiser Permanente Vaccine Study Center Group [see comment]. Pediatric Infectious Disease Journal 2000, 19:187-195.
2. Whitney C.G., Pilishvili T., Farley M.M., Schaffer W., Craig A.S., Lynfield R., et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006, 368:1495-1502.
3. Broome C.V., Facklam R.R., Fraser D.W. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. New England Journal of Medicine 1980, 303:549-552.
4. Hicks L., Harrison L., Flannery B., Hadler J., Schaffner W., Craig A., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Journal of Infectious Diseases 2007, 196:1346-1354.
5. Moore M.R., Gertz R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. Journal of Infectious Diseases 2008, 197:1016-1027.
6. Pelton S.I., Huot H., Finkelstein J.A., Bishop C.J., Hsu K.K., Kellenberg J., et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatric Infectious Disease Journal 2007, 26:468-472.
7. Messina A.F., Katz-Gaynor K., Barton T., Ahmad N., Ghaffar F., Rasko D., et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatric Infectious Disease Journal 2007, 26:461-467.
8. Schuchat A., Hilger T., Zell E., Farley M., Reingold A., Harrison L., et al. Update from the active bacterial core surveillance of the emerging infections program network. Emerging Infectious Diseases 2001, 7:92-99.
9. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. Journal of Infectious Diseases 2010, 201:32-41.
10. Deceuninck G., De Wals P., Boulianne N., De Serres G. Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada. The Pediatric Infectious Disease Journal 2010, 29:546-549. 10.1097/INF.1090b1013e3181cffa1092a.
11. Barzilay E., O'Brien K., Kwuk Y., Hoekstra R., Zell E., Reid R., et al. Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal of vaccination. Vaccine 2005, (epub ahead of print).
12. Dagan R., Givon-Lavi N., Fraser D., Lipsitch M., Siber G., Kohberger R., et al. Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of Pneumococcus. The Journal of Infectious Diseases 2005, 192:367-376.
13. Jokinen J.T., Ãhman H., Kilpi Terhi M., Makela P.H., Kayhty MH Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media. The Journal of Infectious Diseases 2004, 190:545-550.
14. Mahon B.E., Hsu K., Karumuri S., Kaplan S.L., Mason E.O., Pelton S.I., et al. Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens. Vaccine 2006, 24:2514-2520.
15. US Department of Health and Human Services (DHHS). The National Immunization Survey, 2002-2004. National Center for Health Statistics, available at: (accessed 25 May 2010). http://www.cdc.gov/nis/.
16. Nuorti J.P., Martin S.W., Smith P.J., Moran J.S., Schwartz B. Uptake of pneumococcal conjugate vaccine among children in the 1998-2002 United States birth cohorts. American Journal of Preventive Medicine 2008, 34:46-53.
17. Smith P.J., Nuorti J.P., Singleton J.A., Zhao Z., Wolter K.M. Effect of vaccine shortages on timeliness of pneumococcal conjugate vaccination: results from the 2001-2005 National Immunization Survey. Pediatrics 2007, 120:1165-1173.
18. Carvalho Md.G., Pimenta F.C., Jackson D., Roundtree A., Ahmad Y., Millar E.V., et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. Journal of Clinical Microbiology 2010, 48:1611-1618.